Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
BENZOXAZINONE DERIVATIVE
Document Type and Number:
WIPO Patent Application WO/2009/044788
Kind Code:
A1
Abstract:
[PROBLEMS] To provide a compound useful as an agent for the treatment of circulatory diseases, nervous system diseases, metabolic diseases, reproductive system diseases, and digestive tract diseases. [MEANS FOR SOLVING PROBLEMS] The compound, which is for use as an active ingredient, is represented by the formula (I): [wherein R1 represents optionally halogenated C1-6 alkyl, etc.; R2 represents, e.g., a group represented by the formula (II-1) or (II-4) (wherein W represents C1-6 alkylene, etc. and R represents C1-6 alkyl, etc.); R3 represents hydrogen, C1-6 alkyl, etc.; X represents -O-, -NH-, etc.; and Y1, Y2, Y3, and Y4 each independently represents -CH-, -N-, etc.].

Inventors:
ISHIKAWA SHIHO (JP)
MIZUTANI TAKASHI (JP)
NAGASE TSUYOSHI (JP)
SATO NAGAAKI (JP)
TAKAHASHI HIDEKAZU (JP)
Application Number:
PCT/JP2008/067883
Publication Date:
April 09, 2009
Filing Date:
October 02, 2008
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BANYU PHARMA CO LTD (JP)
ISHIKAWA SHIHO (JP)
MIZUTANI TAKASHI (JP)
NAGASE TSUYOSHI (JP)
SATO NAGAAKI (JP)
TAKAHASHI HIDEKAZU (JP)
International Classes:
C07D239/80; A61K31/517; A61K31/536; A61P1/00; A61P1/04; A61P1/10; A61P1/16; A61P1/18; A61P3/00; A61P3/04; A61P3/06; A61P3/10; A61P3/12; A61P5/00; A61P5/24; A61P9/00; A61P9/04; A61P9/06; A61P9/10; A61P9/12; A61P11/00; A61P13/12; A61P15/00; A61P15/08; A61P15/10; A61P17/02; A61P19/02; A61P19/06; A61P25/00; A61P25/02; A61P27/02; A61P29/00; A61P31/00; A61P31/04; A61P31/10; A61P33/00; A61P35/00; A61P37/08; A61P43/00; C07D265/18; C07D403/04; C07D413/04; C07D413/12; C07D413/14; C07D417/12; C07D498/04
Domestic Patent References:
WO2006098969A22006-09-21
WO1995012583A11995-05-11
WO1995020389A11995-08-03
WO1993004047A11993-03-04
WO2000066571A12000-11-09
WO2004013347A22004-02-12
Foreign References:
EP0569083A11993-11-10
EP0582455A11994-02-09
EP0530994A11993-03-10
JP2002543193A2002-12-17
Other References:
MATSUZAKA,T. ET AL.: "Crucial role of a long- chain fatty acid elongase, Elovl6, in obesity- induced insulin resistance", NATURE MEDICINE, vol. 13, no. 10, 1 October 2007 (2007-10-01), pages 1193 - 202, XP008132558
MOON,Y. ET AL.: "Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, no. 48, 2001, pages 45358 - 45366, XP002963525
J. BIOL. CHEM., vol. 276, no. 48, 2001, pages 45358 - 45366
"The Merck Manual of Medical Information", 2003, MERCK & CO.
J. ORG. CHEM., vol. 63, 1998, pages 8536
NOBUO IZUMIYA ET AL.: "Pepuchido Gosei no Kiso to Jikken", 1983, MARUZEN CO., LTD.
T. W. GREENE: "Protective Groups in Organic Synthesis", 1981, JOHN WILEY & SONS
MOON, J. BIOL. CHEM., vol. 276, 2001, pages 45358 - 45366
TETRAHEDRON LETT., vol. 44, 2003, pages 7147
See also references of EP 2210880A4
Attorney, Agent or Firm:
BANYU PHARMACEUTICAL CO., LTD. (1-13-12 Kudankit, Chiyoda-ku Tokyo 67, JP)
Download PDF: